NCT00628576View on ClinicalTrials.gov

Evaluation of Long-Term Sequelae After Thrombophlebitis, i.e. Deep Venous Thrombosis of the Lower Extremities

PHASE3CompletedINTERVENTIONAL
Enrollment

99

Participants

Timeline

Start Date

October 31, 1993

Primary Completion Date

June 30, 2004

Study Completion Date

June 30, 2004

Conditions
Deep Venous Thrombosis
Interventions
DRUG

unfractionated heparin

UFH: Continuous i.v. infusion 100 IU/kg/4hrs initially and then adjusted to maintain APTT value 1.5 - 2.5 the pre-treatment value

DRUG

Tinzaparin (Leo)

FH (Tinzaparin): 175 iu/kg s.c. in the abdomen once daily

Trial Locations (1)

9000

Dept. of Haematology; Aalborg Hospital, Aalborg

All Listed Sponsors
collaborator

Aalborg University

OTHER

lead

Aalborg University Hospital

OTHER